(Q37903708)

25 August 2017

1 reference

title

Naturally occurring inhibitors against the formation of advanced glycation end-products (English)

1 reference

25 August 2017

Xiaofang Peng

1

1 reference

25 August 2017

Jinyu Ma

series ordinal

2

1 reference

25 August 2017

Feng Chen

series ordinal

3

1 reference

25 August 2017

Mingfu Wang

series ordinal

4

1 reference

25 August 2017

language of work or name

1 reference

15 June 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

2

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

289-301

1 reference

Advanced glycation end-products: a review

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Hemoglobin H disease in two Iranian families

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Studies of an unusual hemoglobin in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Lilly Lecture 1993. Glycation and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The botanical extracts of Achyrocline satureoides and Ilex paraguariensis prevent methylglyoxal-induced inhibition of plasminogen and antithrombin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Antioxidant and radical scavenging effects of aged garlic extract and its constituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Mutarotation, Hydrolysis, and Rearrangement Reactions of Glycosylamines1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Unraveling the contribution of melanoidins to the antioxidant activity of coffee brews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Analysis of acrylamide, a carcinogen formed in heated foodstuffs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Experimental and simulation studies of heat flow and heterocyclic amine mutagen/carcinogen formation in pan-fried meat patties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycoxidation end products in commonly consumed foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Protein glycation and oxidative stress in diabetes mellitus and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation: implications in tissue damage and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Early glycation products produce pentosidine cross-links on native proteins. novel mechanism of pentosidine formation and propagation of glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Increased level of glycoxidation product N(epsilon)-(carboxymethyl)lysine in rat serum and urine proteins with aging: link with glycoxidative damage accumulation in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Determination of N epsilon-(carboxymethyl)lysine in foods and related systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Determination of Nepsilon-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The formation of argpyrimidine, a methylglyoxal-arginine adduct, in the nucleus of neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Role of methylglyoxal adducts in the development of vascular complications in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Methylglyoxal comes of AGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Evidence of high levels of methylglyoxal in cultured Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

New insights into protein crosslinking via the Maillard reaction: structural requirements, the effect on enzyme function, and predicted efficacy of crosslinking inhibitors as anti-ageing therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Albumin antioxidant capacity is modified by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Oxidative modification of human ceruloplasmin by methylglyoxal: an in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Incidence and potential implications of the toxic metabolite methylglyoxal in cell culture: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Accumulation of endogenous methylglyoxal impaired insulin signaling in adipose tissue of fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation endproducts in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Carbonyl Stress and Diabetic Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The role of advanced glycation in the pathogenesis of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end products quench nitric oxide in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end-products and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The role of the Maillard reaction in other pathologies: Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Novel inhibitors of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Novel inhibitors of advanced glycation endproducts (part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Alterations of biochemical and biomechanical properties of rat tail tendons caused by non-enzymatic glycation and their inhibition by dibasic amino acids arginine and lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibition of in vitro pyrraline formation by L-arginine and polyamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Increased protein glycation in cirrhosis and therapeutic strategies to prevent it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Carnosine protects against the inactivation of esterase induced by glycation and a steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

2,3-Dimethoxy-5-methyl-1,4-benzoquinones and 2-methyl-1,4-naphthoquinones: glycation inhibitors with lipid peroxidation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Chelating activity of advanced glycation end-product inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Crosslink breakers: a new approach to cardiovascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Therapeutic potential of breakers of advanced glycation end product–protein crosslinks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Renoprotective effects of a novel inhibitor of advanced glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Biological activities of Salacia chinensis originating in Thailand: the quality evaluation guided by alpha-glucosidase inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Flavonol glycosides from the leaves of Eucommia ulmoides O. with glycation inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Two Flavone C-Glycosides from the Style of Zea mays with Glycation Inhibitory Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

A New Flavone C-Glycoside from the Style of Zea mays L. with Glycation Inhibitory Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Activity of wen-pi-tang, and purified constituents of rhei rhizoma and glycyrrhizae radix against glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Tomato paste fraction inhibiting the formation of advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Structural and functional characterization of polyphenols isolated from acerola (Malpighia emarginata DC.) fruit

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Free radical scavenging, anti-glycation and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Protective activity of green tea against free radical- and glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory effects of Luobuma tea and its components against glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Alkaloids and flavonoids from peanut skins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Evaluation of in vitro effects of natural substances of plant origin using a model of protein glycoxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10034C

Protein glycation inhibitors from thyme (Thymus vulgaris)

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.59.2018

Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.54.1315

Chemical constituents of the style of Zea mays L. with glycation inhibitory activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.55.153

Identifiers

DOI

10.1039/C1FO10034C

1 reference

25 August 2017

1 reference